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ABSTRACT
We present a method that allows simultaneous
fusion and cloning of multiple PCR products in a
rapid and efficient manner. The procedure is based
on the use of PCR primers that contain a single
deoxyuridine residue near their 50 end. Treatment of
the PCR products with a commercial deoxyuridine-
excision reagent generates long 30 overhangs
designed to specifically complement each other.
The combination of this principle with the improved
USER cloning technique provides a simple, fast
and very efficient method to simultaneously fuse
and clone multiple PCR fragments into a vector of
interest. Around 90% positive clones were obtained
when three different PCR products were fused and
cloned into a USER-compatible vector in a simple
procedure that, apart from the single PCR amplifi-
cation step and the bacterial transformation, took
approximately one hour. We expect this method to
replace overlapping PCR and the use of type IIS
restriction enzymes in many of their applications.
INTRODUCTION
Seamless PCR product fusion is the process by which two
or more PCR products are joined precisely so that
no undesired base pairs are added at the junction sites.
This is the ideal situation for the countless cases in
which the fusion of PCR products is required (1).
The current method of choice when facing the challenge
of seamlessly assembling several DNA fragments is
overlapping PCR, also called fusion PCR or overlap
extension PCR (2–4). This method was introduced shortly
after the invention of PCR in the mid-1980s and continues
to be the preferred method. The technique is versatile
and eﬃcient, but requires several consecutive PCR
reactions and, therefore, carries an inherent high risk
of PCR-introduced errors. Furthermore, primer design
and PCR conditions usually require optimization when
multiple DNA fragments of considerable size are to be
assembled (5).
Uracil excision-based cloning was conceived in the
early 1990s as an alternative to restriction digest and
ligation-based cloning (6–8). The original method relies
on the use of PCR primers that contain an  12-nt 50 tail
in which at least four deoxyuridines (Us) have been placed
instead of deoxythymidines (Ts). The PCR product is
treated with uracil DNA glycosidase (UDG), which
excises uracil bases selectively while leaving the phospho-
diester backbone intact (9). The abasic sites destabilize
base pairing, which in praxis results in 30 overhangs
that can anneal to similarly produced complementary
30 overhangs in a PCR-ampliﬁed vector (6). Alternatively,
suitable 30 overhangs in a vector can be produced by
ligation of a short U-containing DNA sequence to the
ends of a linearized vector and further treatment with
UDG (7). The treated PCR product and vector are able
to form a stable circular hybridization product that
can be transformed into Escherichia coli without prior
ligation (6,7).
Although early uracil excision-based cloning proved
to be an eﬃcient and versatile technique (up to 1 10
7
transformants mg 1
DNA) (8), several useful modiﬁcations
have been implemented. Watson and Bennett included a
second enzyme in the treatment of PCR products (10). T4
endonuclease V is capable of breaking the DNA
phosphodiester backbone at the 30 side of an abasic site
(11). Therefore, the sequential activity of UDG and T4
endonuclease V on PCR products ampliﬁed with primers
containing a single U residue generates 30 overhangs that
can be used eﬃciently for cloning (10). The commercial
USER
TM Friendly Cloning Kit (New England Biolabs,
launched in 2003) makes use of a similar double enzymatic
treatment. In this cloning technique, the PCR product is
treated with USER
TM enzyme mix, a mixture of UDG
and DNA glycosylase-lyase endo VIII (the exact propor-
tions are not disclosed by the company). The latter
enzyme can break the phosphodiester backbone at the
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deoxyribose is released (12,13). This makes USER
TM
enzyme mix a deoxyuridine-excision reagent.
Furthermore, in the USER
TM Friendly Cloning Kit, the
supplied vector has been prepared by inserting a small
cassette into the multiple cloning site, and subsequently
treating the vector with two restriction endonucleases: a
linearizing one and a nicking one (http://www.neb.com/
nebecomm/ManualFiles/manualE5500.pdf).
Despite the various modiﬁcations to the original
method, uracil excision-based cloning has remained
largely unused (14), most probably because of incompat-
ibility with proof-reading DNA polymerases, which stall
at deoxyuridines present in DNA templates (15,16).
Recently, Nour-Eldin et al. improved the technique by
identifying PfuCx as a compatible proof-reading DNA
polymerase and by developing an improved vector design
strategy (14). We will refer to this technique as ‘improved
USER cloning technique’.
In this article, we describe the assembly of an open
reading frame composed of three diﬀerent DNA frag-
ments (ORF1) by means of a deoxyuridine excision-based
method that combines the fusion of multiple PCR
products with the cloning of the fusion product into
a vector in a single step, without ligation. The advantages
of ‘USER fusion’ are discussed in comparison with other
fusion techniques.
MATERIALS AND METHODS
PCR amplification
Three PCR ampliﬁcations were carried out in parallel
using plasmid templates containing full-length cDNAs of
genes X1 (At2g30860, 648bp), X2 (At4g31500, 1500bp)
and X3 (At5g05260, 1572bp), and primer pairs X1-fwd/
X1-rev, X2-fwd/X2-rev and X3-fwd/X3-rev, respectively.
The sequence of the oligonucleotide primers, all purchased
from Invitrogen, are listed in Table 1. The reactions were
carried out using PfuTurbo CX Hotstart DNA polymer-
ase (Stratagene) according to the manufacturer’s
instructions. Additionally, 5% DMSO was included in
the reaction that ampliﬁed X2 cDNA.
DNA purification
The PCR products were column-puriﬁed using QIAquick
PCR puriﬁcation kit (QIAGEN) according to the
manufacturer’s instructions. Puriﬁed PCR products were
eluted with water in one-third of the original volume.
Mixture ofpurified PCRproducts and pre-digested vector
An aliquot of the puriﬁed PCR products, along with
an aliquot of a stock of PacI/Nt.BbvCI pre-digested
pCAMBIA330035Su ( 9.5kb) (14), was run on an
agarose gel to estimate relative concentrations. The four
components were mixed in approximate 10:10:10:1 molar
ratios, where the unit refers to pre-digested vector.
Treatment with USER
TMenzyme mix
One microliter of 10  TE buﬀer [100mM Tris-HCl, 1mM
EDTA (pH 8.0)] and 1U of USER
TM enzyme mix
(New England Biolabs, 1U/ml) were added to 8ml of the
mixture of puriﬁed PCR products and pre-digested vector.
The reaction mixture was incubated for 20min at 378C,
followed by 20min at 258C. The approximate amount of
pre-digested vector in the reaction mixture was 0.01pmol.
Transformation
The entire USER-treated reaction mixture (10ml) was used
to transform 50ml of chemically competent E. coli cells by
heat shock.
Plasmid preparationsand restriction analysis
Plasmid preparations were made from 4ml overnight
cultures using GenElute
TM Plasmid Miniprep Kit
(Sigma-Aldrich) according to the manufacturer’s
instructions. The puriﬁed plasmids were eluted in 50ml
of water. Two microliters of each plasmid miniprep were
cut for 2h at 378C with 10U of SpeI (New England
Biolabs) in 20ml reactions that contained 1 NEB Buﬀer 2
Table 1. Oligonucleotide primers used for the assembly of ORF1 by USER fusion
Target-speciﬁc sequences are presented in italics. Restriction sites are presented in bold. The identity of each of the underlined sequences is written
beneath them. U residues are shaded in black, while the regions shaded in grey correspond to the oligonucleotides that will be displaced after
treatment with USER
TM enzyme mix.
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dithiothreitol (pH 7.9)] and 100mg/ml BSA.
RESULTS
ORF1 is composed of the coding regions of genes X1,
X2 and X3, linked by two diﬀerent  60-bp linkers, L1
(between X1 and X2) and L2 (between X2 and X3)
(Figure 1A). The entire ORF1 has a length of  3.9kb.
The fusion and cloning principle used for the assembly
of ORF1 is depicted in Figure 1B. The coding regions
of X1, X2 and X3 were ampliﬁed using primers that
contained a single deoxyuridine (instead of a deoxythy-
midine) near their 50 end. The L1 sequence was included as
two separate fragments in primers X1-rev and X2-fwd,
and the L2 sequence was similarly included in primers
X2-rev and X3-fwd so that both  60-bp linkers were
constructed after the fusion procedure. The deoxyuridine
residues in these four primers were located 6–8 residues
downstream from a 50 terminal deoxyadenosine. The
puriﬁed PCR products were mixed with a pre-digested
USER-compatible vector and treated with the
Figure 1. (A) Outline of ORF1. The coding regions of genes X1, X2, and X3 are linked together by two diﬀerent  60-bp linkers, L1 and L2. ORF1
has a length of  3.9kb. (B) Assembly of ORF1. X1, X2 and X3 sequences were ampliﬁed using primers that contained a single U (instead of a T)
near their 50 end. The L1 sequence was included as two separate fragments in primers X1-rev and X2-fwd, and the L2 sequence was similarly
included in primers X2-rev and X3-fwd so that both  60-bp linkers were constructed after the fusion procedure. The PCR products were mixed
with a pre-digested USER-compatible vector and treated with the deoxyuridine-excising USER
TM enzyme mix. This generated 30 overhangs that
were designed so that the internal ones complemented each other (indicated by arrows), while the outermost ones complemented the overhangs of
the pre-digested vector. This design enabled the formation of a stable circular hybridization product that was transformed directly into E. coli
without prior ligation.
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TM enzyme mix. Ablation of
the deoxyuridines from the PCR products resulted in the
generation of 7–9nt-long overhangs. The 7-nt overhang
generated with primer X1-rev was designed to comple-
ment the 7-nt overhang generated with primer X2-fwd,
and a similar design had been made for the 9-nt overhangs
generated with primers X2-rev and X3-fwd. The 8-nt
overhangs generated with primers X1-fwd and X3-rev
complemented the overhangs present in the pre-digested
vector. A short incubation at 258C ensured the formation
of a stable circular hybridization product that was ready
for transformation into E. coli without prior ligation.
This procedure thus allowed simultaneous fusion and
insertion of the three PCR products into the pre-digested
vector. When using  0.01pmol of pre-digested vector,
 100 colonies were obtained in two replicates derived
from two separate enzymatic treatments.
Primers X1-fwd and X3-rev carried two unique restric-
tion sites each, between the target-speciﬁc sequence and
the deoxyuridine residue (Table 1). These sites were
included for future sub-cloning purposes. We used SpeI
sites present in both primers X1-fwd and X3-rev for
restriction analysis of plasmids containing a full-length
ORF1. The analysis of plasmid preparations from
32 independent colonies showed an  3.9-kb fragment in
29 preparations (Figure 2). Two positive plasmids were
sequenced. The sequencing results showed that both
ORF1 sequences were free of polymerase-introduced
errors and that they had been inserted in the correct
orientation.
DISCUSSION
We describe a method in which multiple PCR products
are fused and cloned simultaneously into a vector of
interest. The fusion principle makes use of deoxyuridine-
containing primers and an enzymatic treatment to
generate long overhangs by 50 partial primer removal.
Overhangs of the individual PCR products are designed to
complement the appropriate overhangs of other products,
thus making the fusion process possible. The combina-
tion of this principle with the improved USER cloning
technique (14), results in a simple, fast and very eﬃcient
method to fuse and clone multiple PCR fragments into
a vector in a single step.
The fusion principle was originally introduced by Booth
et al. (17) and by Watson and Bennett (10) (10,17).
However, their methods do not seem to have been applied
elsewhere, as evidenced by the lack of citations. Booth
et al. (1994) used the original uracil excision-based cloning
(several Us per primer and only UDG for the enzymatic
treatment), and managed to clone the fusion product
without ligation. In two separate experiments, each
involving two PCR products, only two out of forty, or
six out of ten randomly selected colonies contained the
desired insert (17). We have shown that, in the USER
fusion of three PCR products, 29 out of 32 randomly
selected colonies contained the desired insert ( 90%).
The higher percentage of positive colonies is explained
by the fact that the USER
TM enzyme mix contains
both UDG and DNA glycosylase-lyase Endo VIII, and
is therefore capable of generating overhangs (see the
Introduction section). On the other hand, Watson and
Bennett did use two diﬀerent enzymes to generate over-
hangs in their PCR products (each primer carrying a single
U) and they reported very high cloning eﬃciencies.
However, as opposed to USER fusion, the cloning
required ligation, since it was made into a SpeI-cut
vector (4-nt overhangs) (10). When Nour-Eldin et al.
reported the improved USER cloning technique, they
suggested a sequential insertion of PCR products in order
to achieve fusions. This leads to the inclusion of a 13-bp
sequence at the joining site (14). The novelty in our
method lies in the combination of the fusion principle
with the improved USER cloning technique. With USER
fusion, multiple PCR products can be fused seamlessly
and cloned into a vector of interest in a single step,
without ligation.
In USER fusion, the primer design is ﬂexible. The only
requirement, when examining the sequence of a desired
fusion product, is the presence of a deoxythymidine (T)
located  8nt downstream from a deoxyadenosine (A)
in the proximity of each junction site (Figure 3). The
sequence of the forward primers start with the selected
A and has a U instead of the selected T. An analog
situation occurs with the reverse primers. This design
allows the creation of complementary overhangs of  8nt
during the fusion process.
We have successfully used overhangs of 7–9nt, but
longer overhangs are also expected to work eﬃciently.
If very long overhangs are required, the replacement
of several Ts for Us in the overlapping parts of the
primers (and not only the most downstream T) is
Figure 2. Agarose gel showing a restriction analysis of potential ORF1-
containing plasmids. Plasmids from 32 independent colonies were
digested using SpeI enzyme and run on an agarose gel. An aliquot of a
molecular weight marker was loaded in the outermost lanes and in the
middle lane. An  3.9-kb band (black arrow), which represents the full-
length ORF1, was seen in 29 out of the 32 digestions ( 90%). Figure 3. Primer design in USER fusion. The blue lines encompass the
desired DNA fusion product, in which X and Y are any pair of
complementary deoxynucleotides. Only the sequence near a junction
site is shown. The only requirement for USER fusion is the presence of
a T located  8 residues downstream from an A (both residues shaded
in black, as well as their complementary residues) in the proximity of
the junction site. The sequences of the reverse primer (that will amplify
the upstream fragment) and the forward primer (that will amplify the
downstream fragment) are shown. In both primers, the selected T is
replaced by a U (shaded in red).
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primers. We recommend having diﬀerent overhang lengths
for the diﬀerent junction sites because it minimizes the
risk of incorrect combinations of overhangs annealing
together. However, as a single nucleotide diﬀerence in the
overhangs used for improved USER cloning is able to
eﬃciently confer directionality (14), we predict that similar
simultaneous fusion and cloning processes would be
eﬃcient even when non-complementary overhangs are
of the same length.
We have mentioned that, for USER fusion,
appropriate A and T residues must be identiﬁed in the
desired fusion sequence, proximal to the junction site.
The actual location of the selected residues in relation to
the junction site may, however, vary. Six diﬀerent cases,
which illustrate the ﬂexibility of the design in USER
fusion, are presented in Figure 4.
Based on the high eﬃciency of the assembly of ORF1
( 100 colonies per 0.01pmol of pre-digested vector), we
believe that three is not the maximum number of PCR
products of similar size that can be simultaneously fused
and cloned with USER fusion. This maximum number
is likely to be dependent on the size of the individual
fragments and recipient vector.
In comparison with overlapping PCR, the primers
needed for USER fusion are shorter. Typically 15-nt
overlaps are needed for overlapping PCR (18), while
deoxyuridine-containing primers need only to have
overlaps of  8nt. In contrast to USER fusion, over-
lapping PCR needs secondary PCR ampliﬁcation steps
and therefore carries a high risk of PCR-induced errors.
Finally, overlapping PCR yields a full-length product that
for many applications still needs to be cloned into
a vector. In USER fusion, the full-length product is
cloned into the destination vector in the same step.
Type IIS restriction enzymes cleave outside their
recognition sequences (e.g. SapI or Esp3I), and are
therefore capable of producing overhangs of any given
sequence. When the cleavage is designed to occur between
the recognition sites and the core of the PCR products,
these enzymes are able to mediate seamless fusion of
DNA amplicons (1,19). In comparison to USER fusion,
the overhangs created by type IIS endonucleases are
shorter (typically 3 or 4nt long). This creates a need
for ligation prior to transformation. Moreover, the PCR
products are required not to contain any of the restric-
tion sites that have been attached to their ends. Apart
from being a hurdle in primer design, this condition
usually introduces the necessity of using diﬀerent enzymes
or enzyme pairs for each of the PCR products to
be fused, which in turn decreases the simplicity of the
procedure.
It is worth noting that the fusion principle by itself
(when not combined with the improved USER cloning)
has several potential applications, now that U-containing
PCR products can be ampliﬁed with a proof-reading
Figure 4. Strategies for USER fusion. The two colored strands in the middle of each ﬁgure represent the desired DNA fusion product. The fragments
to be joined together are presented in red (left) and in blue (right). In cases (C), (D), (E) and (F), a linker (gray) is desired at the junction site.
The arrows represent the primers designed for USER fusion, and their color code indicates the origin of their sequence. (A) The selected A and T
residues surround the junction site. (B) Both residues are chosen at one side of the junction site. (C) The A and T residues lie in the linker itself, and
the linker sequence is partially included in each primer. (D) Both residues are chosen at one side of the linker, and the entire linker sequence is
included in the primer that ampliﬁes the sequence at the other side. (E) The residues are located at each side of the linker, and the entire linker
sequence is included in both primers. (F) The residues are located at each side of the linker, but the linker sequence is not included in any of the
primers. Two complementary oligonucleotides that carry the linker sequence are used as an intermediate DNA fragment to be fused.
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quickly construct a gene disruption cassette (50-ﬂanking
sequenceþmarkerþ30-ﬂanking sequence) that could be
used directly or after ligation (but without secondary PCR
ampliﬁcation or cloning) for gene disruption in organisms
that require long ﬂanking homology regions for eﬀective
integration into the genome. It might also be useful in
assembling full-length infectious viral cDNAs. For these
two applications, overlapping PCR and the use of type
IIS restriction endonucleases have been the preferred
strategies (5,19).
In conclusion, USER fusion is a simple, fast and very
eﬃcient method to fuse seamlessly and clone multiple
PCR products into a vector of interest. Because of its
positive features, we expect USER fusion to replace
overlapping PCR and the use of type IIS restriction
enzymes in many of their applications.
ACKNOWLEDGEMENTS
This work was supported by the Danish International
Developmental Agency (DANIDA, project 91175) and by
the Danish National Research Foundation through its
support to the Center for Molecular Plant Physiology
(PlaCe). Funding to pay the Open Access publication
charge was provided by the Danish National Research
Foundation.
Conﬂict of interest statement. It is noted that the subject
matter of this publication is included in an international
patent application ﬁled by co-inventors FEG, HHN,
BAH, et al. on March 5, 2007, under the Patent
Cooperation Treaty. This application claims priority to
a United Kingdom patent application, number 0610045.7,
ﬁled on May 19, 2006, in connection with Plant
Biosciences Limited, a United Kingdom-based technology
transfer enterprise.
REFERENCES
1. Lu,Q. (2005) Seamless cloning and gene fusion. Trends Biotechnol.,
23, 199–207.
2. Higuchi,R., Krummel,B. and Saiki,R. (1988) A general method of
in vitro preparation and speciﬁc mutagenesis of DNA fragments:
study of protein and DNA interactions. Nucleic Acids Res., 16,
7351–7367.
3. Ho,S.N., Hunt,H.D., Horton,R.M., Pullen,J.K. and Pease,L.R.
(1989) Site-directed mutagenesis by overlap extension using the
polymerase chain reaction. Gene, 77, 51–59.
4. Horton,R.M., Hunt,H.D., Ho,S.N., Pullen,J.K. and Pease,L.R.
(1989) Engineering hybrid genes without the use of
restriction enzymes: gene splicing by overlap extension. Gene, 77,
61–68.
5. Shevchuk,N.A., Bryksin,A.V., Nusinovich,Y.A., Cabello,F.C.,
Sutherland,M. and Ladisch,S. (2004) Construction of long DNA
molecules using long PCR-based fusion of several fragments
simultaneously. Nucleic Acids Res., 32, e19.
6. Nisson,P.E., Rashtchian,A. and Watkins,P.C. (1991) Rapid
and eﬃcient cloning of Alu-PCR products using uracil DNA
glycosylase. PCR Methods Appl., 1, 120–123.
7. Rashtchian,A., Thornton,C.G. and Heidecker,G. (1992) A novel
method for site-directed mutagenesis using PCR and uracil DNA
glycosylase. PCR Methods Appl., 2, 124–130.
8. Rashtchian,A. (1995) Novel methods for cloning and engineering
genes using the polymerase chain reaction. Curr. Opin. Biotechnol.,
6, 30–36.
9. Lindahl,T., Ljungquist,S., Siegert,W., Nyberg,B. and Sperens,B.
(1977) DNA N-glycosidases: properties of uracil-DNA glycosidase
from Escherichia coli. J. Biol. Chem., 252, 3286–3294.
10. Watson,D.E. and Bennett,G.N. (1997) Cloning and assembly of
PCR products using modiﬁed primers and DNA repair enzymes.
Biotechniques, 23, 858–862, 864.
11. Friedburg,E.C., Walker,G.C. and Siede,W. (1995) DNA Repair and
Mutagenesis. ASM Press, Washington, DC.
12. Jiang,D., Hatahet,Z., Melamede,R.J., Kow,Y.W. and Wallace,S.S.
(1997) Characterization of Escherichia coli Endonuclease VIII.
J. Biol. Chem., 272, 32230–32239.
13. Melamede,R.J., Hatahet,Z., Kow,Y.W., Ide,H. and Wallace,S.S.
(1994) Isolation and characterization of endonuclease VIII from
Escherichia coli. Biochemistry, 33, 1255–1264.
14. Nour-Eldin,H.H., Hansen,B.G., Norholm,M.H.H., Jensen,J.K. and
Halkier,B.A. (2006) Advancing uracil-excision based cloning
towards an ideal technique for cloning PCR fragments. Nucleic
Acids Res., 34, e122.
15. Lasken,R.S., Schuster,D.M. and Rashtchian,A. (1996)
Archaebacterial DNA polymerases tightly bind uracil-containing
DNA. J. Biol. Chem., 271, 17692–17696.
16. Sakaguchi,A.Y., Sedlak,M., Harris,J.M. and Sarosdy,M.F. (1996)
Cautionary note on the use of dUMP-containing PCR primers with
Pfu and VentR DNA polymerases. Biotechniques, 21, 368–370.
17. Booth,P.M., Buchman,G.W. and Rashtchian,A. (1994) Assembly
and cloning of coding sequences for neurotrophic factors directly
from genomic DNA using polymerase chain reaction and uracil
DNA glycosylase. Gene, 146, 303–308.
18. Higuchi,R. (1990). Recombinant PCR. In Innis,M.A.,
Gelfand,D.H., Sninsky,J.J. and White,T.J. (eds), PCR Protocols.
A Guide to Methods and Applications. Academic Press, Inc,
San Diego, CA.
19. Yount,B., Denison,M.R., Weiss,S.R. and Baric,R.S. (2002)
Systematic assembly of a full-length infectious cDNA of mouse
hepatitis virus strain A59. J. Virol., 76, 11065–11078.
e55 Nucleic Acids Research, 2007, Vol. 35, No. 7 PAGE 6 OF6